The company has welcomed a new guidance note from the FCA and is confident it meets the requirements for LSE listing.
Zelira Therapeutics Ltd (ASX:ZLD) managing director Richard Hopkins speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. The medicinal cannabis company owns a portfolio of proprietary revenue-generating products and a pipeline of candidates undergoing...
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.